ASX-Dividend-Report-Banner

Apollo Hospitals Celebrates 25 Years of India's First Liver Transplant Program

November 16, 2023 05:41 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Apollo Hospitals Celebrates 25 Years of India's First Liver Transplant Program
Image source: Kalkine Media
  • Apollo Hospitals pioneered India's first successful liver transplant in 1998.
  • The first liver transplant patient, who was 20 months old at the time, is now a doctor.
  • Apollo Hospitals has played a leading role in positioning India as a global leader in organ transplantation

NEW DELHI, Nov. 16, 2023 /PRNewswire/ -- Apollo, the world's largest integrated healthcare provider, completed 25 years of liver transplant program in India with over 4300 liver transplants, including 515 in children from over 50 countries. Today, Apollo performs more than 1600 solid organ transplants a year. With 90% success rates, The Apollo Liver Transplant program is a beacon of quality and hope for patients from across the world.

(Left to right)) Dr. Sanjay Kandaswamy (India's first LT patient who is now a doctor), Dr. Anupam Sibal, Ms. Dimple Kapadia, Baby Prisha with her parent, Mr. Shivakumar Pattabhiraman, Dr. Neerav Goyal
(Left to right)) Dr. Sanjay Kandaswamy (India's first LT patient who is now a doctor), Dr. Anupam Sibal, Ms. Dimple Kapadia, Baby Prisha with her parent, Mr. Shivakumar Pattabhiraman, Dr. Neerav Goyal

Dr. Preetha Reddy, Vice Chairperson, Apollo Hospitals Group, said, "At Apollo, our dedication lies in ensuring that no individual succumbs due to a lack of access to transplantation. Our focus involves establishing top-tier transplant centres, led by esteemed clinicians. We are committed to extending our expertise to individuals worldwide seeking liver transplant services."

Dr. Anupam Sibal, Group Medical Director & Senior Pediatric Gastroenterologist, said, "In the last 25 years, the liver transplant program at Apollo Institutes has achieved remarkable milestone giving hope to patients with end-stage liver diseases. Sanjay Kandasamy, India's first liver transplant recipient is now a successful doctor, a beacon of hope for those with no hope. Success stories of our patients have encouraged us to create the most advanced transplant ecosystem, performing complex transplants such as ABO incompatible, combined liver-kidney transplants, and in babies weighing just 4 kgs."

Dr. Neerav Goyal, Sr. Consultant, Liver Transplants, said, "With a remarkable 90% success rate, Apollo's liver transplant program embodies unwavering commitment, serving as a beacon of hope for liver failure patients. Our intent is to expand further, extending renewed chances for a healthier life."

The Apollo Transplant program is one of the world's largest and most comprehensive transplant programs that manages wide range of liver disease and kidney disease, liver and kidney transplantation, heart and lung transplantation, intestinal, pancreas and GI transplant surgeries and podiatric transplant services.

About Indraprastha Apollo Hospitals:

Established in July 1996, Indraprastha Apollo Hospitals, India's inaugural JCI accredited hospital, is a collaborative effort between the Delhi Government and Apollo Hospitals Enterprise Limited. Spanning 15 acres, it stands as the third super-specialty tertiary care facility by the Apollo Hospitals Group. Boasting 57 specialties, over 300 specialists, and 700 operational beds, the hospital is equipped with 19 operation theatres, 138 ICU beds, 24-hour emergency services, and an air ambulance. A trailblazer in kidney and liver transplants, it witnessed India's first successful pediatric and adult liver transplants. Renowned for cutting-edge medical technology, including 64-slice CT, 3 Tesla MRI, Novalis Tx, and integrated PET Suite, the hospital leads in diagnostic, medical, and surgical facilities. With decades of satisfied clientele, Indraprastha Apollo remains at the forefront of healthcare excellence.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.